Chemkart invests ₹1.30 crore in subsidiary Easy Raw Materials
- Chemkart invests ₹1.30 crore in subsidiary Easy Raw Materials via rights issue
- Subsidiary reports nil turnover with net worth of ₹578.60 lakh as on March 31, 2026
- Funds utilized for commissioning manufacturing unit per IPO prospectus

*this image is generated using AI for illustrative purposes only.
Chemkart India Limited has invested ₹1.30 crore in its wholly owned subsidiary, Easy Raw Materials Private Limited, through a rights issue. The transaction involves the allotment of 13,00,000 equity shares at face value.
The investment aligns with the utilization of proceeds specified in the company’s Initial Public Offer prospectus dated July 10, 2025. The funds are designated for commissioning the manufacturing unit of the subsidiary.
Transaction Details
Chemkart acquired the shares at an issue price of ₹10 per equity share, matching the face value. This brings the total consideration to ₹1.30 crore. The company held 100% of the subsidiary’s shares both before and after this allotment.
| Metric | Details |
|---|---|
| Target Entity | Easy Raw Materials Private Limited |
| Investment Amount | ₹1.30 crore |
| Shares Allotted | 13,00,000 Equity Shares |
| Issue Price | ₹10 per share |
| Shareholding Post-Allotment | 100% |
Subsidiary Financial Position
Easy Raw Materials Private Limited operates in the trading of pharma products and nutritional supplements. Incorporated in 2020, the entity reported nil turnover for the last three years. As on March 31, 2026, the subsidiary recorded a loss after tax of ₹59.47 lakh against a net worth of ₹578.60 lakh.
The paid-up share capital of the subsidiary stands at ₹9.81 crore, divided into 98,10,000 equity shares of ₹10 each. The authorized share capital is ₹10 crore.
Regulatory Compliance
The transaction falls under related-party transactions as per SEBI regulations. Chemkart disclosed the investment under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated the transaction was conducted at arm’s length. No governmental or regulatory approvals were required for this acquisition.
Historical Stock Returns for Chemkart
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.99% | -1.50% | -5.73% | +73.13% | -9.75% | -30.60% |
How will the commissioning of Easy Raw Materials' manufacturing unit impact Chemkart's vertical integration strategy and supply chain resilience?
What is the projected timeline for Easy Raw Materials to transition from nil turnover to generating significant revenue post-commissioning?
Will Chemkart need to inject additional capital beyond the ₹1.30 crore to cover operational costs and working capital requirements for the new facility?


































